Booster COVID19 vaccine shot season begins: Eligible groups for shots expanded by CDC Head


Although the debate on who is eligible for booster shots was on for more than four weeks, a list of eligible adults has been prepared. Statements from Presidential Biden, governors, pharmacies and the CDC head are out encouraging Americans to get their COVID-19 booster vaccine dose. On Friday, President Biden said that about 60 million Americans are eligible or will be eligible to get a shot soon.


Advisors at the Centers said Disease Control and Prevention (CDC) had presented a truncated list of adults eligible for a booster show but Dr. Rochelle Walensky, expanded the list that is aligned to recommendations by the Food and Drug Administration. The current list of eligible adults is:


  • Adults aged 65 and above
  • Nursing home and assisted living facilities’ residents
  • Adults between 18-64 years with an underlying medical condition
  • Adults between 18-64 years who face increased risks due to occupations or institutional settings.


The underlying medical conditions that qualify for a booster shot include


  • Asthma
  • Diabetes
  • COPD
  • High blood pressure
  • Overweight or Obesity
  • Pregnancy
  • Sickle cell disease
  • Smoking disorders
  • Substance abuse disorders.


Those who are considered to have an increased risk of being exposed to COVID-19 include those who work in-person that is still a fairly large percentage of the American population. Some of them could include


  • Healthcare workers
  • Teachers
  • Grocery store workers
  • Workers at airports and large transportation hub


The Pfizer-BioNTech shot has been administered to over 100 million people across the nation. A huge chunk of this vaccinated population will soon be eligible for a booster shot. As of now, only Pfizer’s booster shot has received emergency use approval from the FDA.


Although Moderna and Johnson & Johnson’s booster shots have not as yet received approval, it is not a worrisome factor as the Pfizer shot lost a lot of efficacy in six months, according to compiled data, while the Moderna efficacy fell by only one percent.

Follow us on Google news for more updates and News

Full Disclaimer



Get the most important news and analyses for Free.

Thank you for subscribing.

Something went wrong.